The early stage of biotech drug development can be a valley of death, but a renewed interest in U.S. federal nondilutive capital and mission driven family offices is quietly revising the investment playbook. A 2024-2025 analysis of biotechs navigating the funding crunch reported that 38% of seed-stage companies planned to make nondilutive funding a corestrategy....

The Bridgewater founder dismissed bitcoin's safe-haven credentials on the same day gold dropped 3% while bitcoin fell less than 1%.

As a historian, I’ve studied the major consumer boycotts of history. We can take down ChatGPT and send a powerful signal to Silicon Valley, says author and historian Rutger Bregman